352 related articles for article (PubMed ID: 23061719)
1. The significance of ubiquitin proteasome pathway in cancer development.
Yerlikaya A; Yöntem M
Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):298-309. PubMed ID: 23061719
[TBL] [Abstract][Full Text] [Related]
2. Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials.
Nabavi SF; Atanasov AG; Khan H; Barreca D; Trombetta D; Testai L; Sureda A; Tejada S; Vacca RA; Pittalà V; Gulei D; Berindan-Neagoe I; Shirooie S; Nabavi SM
Cancer Lett; 2018 Oct; 434():101-113. PubMed ID: 30030139
[TBL] [Abstract][Full Text] [Related]
3. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-proteasome pathway an emerging anticancer strategy for therapeutics: a patent analysis.
Jain CK; Arora S; Khanna A; Gupta M; Wadhwa G; Sharma SK
Recent Pat Anticancer Drug Discov; 2015; 10(2):201-13. PubMed ID: 25877716
[TBL] [Abstract][Full Text] [Related]
5. Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.
Devine T; Dai MS
Curr Pharm Des; 2013; 19(18):3248-62. PubMed ID: 23151129
[TBL] [Abstract][Full Text] [Related]
6. The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer.
Yerlikaya A; Kanbur E; Stanley BA; Tümer E
Anticancer Agents Med Chem; 2021; 21(1):20-32. PubMed ID: 32781973
[TBL] [Abstract][Full Text] [Related]
7. Targeting Deubiquitinating Enzymes and Autophagy in Cancer.
Mooneyham A; Bazzaro M
Methods Mol Biol; 2017; 1513():49-59. PubMed ID: 27807830
[TBL] [Abstract][Full Text] [Related]
8. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy.
Aliabadi F; Sohrabi B; Mostafavi E; Pazoki-Toroudi H; Webster TJ
Open Biol; 2021 Apr; 11(4):200390. PubMed ID: 33906413
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-interacting motifs of S5a as a unique upstream inhibitor of the 26S proteasome.
Elangovan M; Shin DY; Yoo YJ
Biochem Biophys Res Commun; 2009 Oct; 388(4):723-6. PubMed ID: 19695230
[TBL] [Abstract][Full Text] [Related]
11. Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition.
Patel K; Ahmed ZS; Huang X; Yang Q; Ekinci E; Neslund-Dudas CM; Mitra B; Elnady FA; Ahn YH; Yang H; Liu J; Dou QP
Future Med Chem; 2018 Sep; 10(17):2087-2108. PubMed ID: 30066579
[TBL] [Abstract][Full Text] [Related]
12. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
13. Targeting the ubiquitin+proteasome system in solid tumors.
Driscoll JJ; Woodle ES
Semin Hematol; 2012 Jul; 49(3):277-83. PubMed ID: 22726552
[TBL] [Abstract][Full Text] [Related]
14. The role of the ubiquitin-proteasome pathway in cancer development and treatment.
Ding F; Xiao H; Wang M; Xie X; Hu F
Front Biosci (Landmark Ed); 2014 Jun; 19(6):886-95. PubMed ID: 24896323
[TBL] [Abstract][Full Text] [Related]
15. When ubiquitin meets NF-κB: a trove for anti-cancer drug development.
Wu ZH; Shi Y
Curr Pharm Des; 2013; 19(18):3263-75. PubMed ID: 23151140
[TBL] [Abstract][Full Text] [Related]
16. Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.
Allende-Vega N; Saville MK
Semin Cancer Biol; 2010 Feb; 20(1):29-39. PubMed ID: 19897040
[TBL] [Abstract][Full Text] [Related]
17. The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.
Ao N; Chen Q; Liu G
Comb Chem High Throughput Screen; 2017; 20(5):403-413. PubMed ID: 28699494
[TBL] [Abstract][Full Text] [Related]
18. Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy.
Frezza M; Schmitt S; Dou QP
Curr Top Med Chem; 2011 Dec; 11(23):2888-905. PubMed ID: 21824109
[TBL] [Abstract][Full Text] [Related]
19. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
Daks AA; Melino D; Barlev NA
Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
[TBL] [Abstract][Full Text] [Related]
20. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
Staszczak M
Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
